Filing Details
- Accession Number:
- 0001209191-23-041798
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-07-07 16:26:27
- Reporting Period:
- 2023-07-05
- Accepted Time:
- 2023-07-07 16:26:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
81362 | Quaker Chemical Corp | KWR | Miscellaneous Products Of Petroleum & Coal (2990) | 230993790 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1935345 | Melissa Leneis | 901 E. Hector Street Conshohocken PA 19428 | Evp, Chro | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-07-05 | 2,578 | $194.89 | 7,623 | No | 4 | F | Direct | |
Common Stock | Disposition | 2023-07-07 | 4,445 | $195.61 | 3,178 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Shares surrendered by reporting person to satisfy withholding tax obligation upon vesting of restricted stock granted on July 5, 2022 under the Company's 2016 Long-Term Performance Incentive Plan.
- The sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on November 22, 2022.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.38 to $195.80, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.